Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 45790W108 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Pivotal bioVenture Partners Fund I, L.P.
13D/A
Amendment 5
|
0% |
8/27/2025
Event 7/1/2025
|
|
| Pivotal bioVenture Partners Fund I, L.P. | 0% | ||
| Pivotal bioVenture Partners Fund II, L.P. | 0% | ||
| Pivotal bioVenture Partners Fund II G.P. Ltd | 0% | ||
| Pivotal bioVenture Partners Fund I G.P., L.P. | 0% | ||
| Pivotal bioVenture Partners Fund I U.G.P. Ltd | 0% | ||
| Pivotal Partners Ltd | 0% | ||
| Pivotal Life Sciences Holdings Limited | 0% | ||
| Nan Fung Life Sciences Holdings Limited | 0% | ||
| NF Investment Holdings Limited | 0% | ||
| Nan Fung Group Holdings Limited | 0% | ||
|
Beryl Capital Management LLC
13G/A
Amendment 1
|
0% |
8/14/2025
Event 6/30/2025
|
|
| Beryl Capital Management LLC | 0% | ||
| Beryl Capital Management LP | 0% | ||
| Beryl Capital Partners II LP | 0% | ||
| David A. Witkin | 0% | ||
|
Rock Springs Capital Management LP
13G/A
Amendment 3
|
0% |
8/13/2025
Event 6/30/2025
|
|
| Rock Springs Capital Management LP | 0% | ||
| Rock Springs Capital LLC | 0% | ||
| Rock Springs Capital Master Fund LP | 0% | ||
| Mark Bussard | 0% | ||
| Kris Jenner | 0% | ||
|
Adage Capital Management, L.P.
13G/A
Amendment 4
|
0% |
8/12/2025
Event 6/30/2025
|
|
| Adage Capital Management, L.P. | 0% | ||
| Robert Atchinson | 0% | ||
| Phillip Gross | 0% | ||
| BlackRock, Inc. 13G/A Amendment 1 | 4.1% |
7/17/2025
Event 6/30/2025
|
|
|
Glazer Capital, LLC
13G
|
6.6% |
6/4/2025
Event 5/28/2025
|
|
| Glazer Capital, LLC | 6.6% | ||
| Paul J. Glazer | 6.6% | ||
|
Affinity Asset Advisors, LLC
13G/A
Amendment 1
|
2.9% |
5/30/2025
Event 5/20/2025
|
|
| Affinity Healthcare Fund, LP | 2.9% | ||
| Affinity Asset Advisors, LLC | 2.9% | ||
|
Beryl Capital Management LLC
13G
|
9.8% |
5/23/2025
Event 5/16/2025
|
|
| Beryl Capital Management LLC | 9.8% | ||
| Beryl Capital Management LP | 9.8% | ||
| Beryl Capital Partners II LP | 7.9% | ||
| David A. Witkin | 9.8% | ||
|
Eventide Asset Management, LLC
13G/A
Amendment 2
|
3.5% |
4/23/2025
Event 12/31/2024
|
|
| Eventide Asset Management, LLC | 3.5% | ||
| Finny Kuruvilla, M.D., Ph. D. | 3.5% | ||
| Robin C. John | 3.5% | ||
|
Eventide Asset Management, LLC
13G/A
Amendment 2
|
3.5% |
2/14/2025
Event 12/31/2024
|
|
| Eventide Asset Management, LLC | 3.5% | ||
| Finny Kuruvilla, M.D., Ph. D. | 3.5% | ||
| Robin C. John | 3.5% | ||
|
Samlyn Capital, LLC
13G/A
Amendment 1
|
0% |
2/14/2025
Event 12/31/2024
|
|
| Samlyn Capital, LLC | 0% | ||
| Samlyn, LP | 0% | ||
| Robert Pohly | 0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q2 | 91 | 50.6 M | $202 M |
| 2025 Q1 | 100 | 46.7 M | $42.5 M |
| 2024 Q4 | 108 | 52.4 M | $145 M |
| 2024 Q3 | 93 | 54.6 M | $286 M |
| 2024 Q2 | 96 | 53.9 M | $241 M |
| 2024 Q1 | 96 | 50.2 M | $384 M |
| 2023 Q4 | 88 | 50.6 M | $216 M |
| 2023 Q3 | 84 | 48.7 M | $205 M |
| 2023 Q2 | 79 | 34.2 M | $190 M |
| 2023 Q1 | 55 | 32.0 M | $183 M |
| 2022 Q4 | 39 | 29.0 M | $30.5 M |
| 2022 Q3 | 41 | 31.5 M | $84.6 M |
| 2022 Q2 | 48 | 31.5 M | $149 M |
| 2022 Q1 | 51 | 17.4 M | $71.2 M |
| 2021 Q4 | 52 | 17.3 M | $118 M |
| 2021 Q3 | 53 | 17.5 M | $203 M |
| 2021 Q2 | 51 | 19.8 M | $337 M |
| 2021 Q1 | 56 | 19.2 M | $379 M |
| 2020 Q4 | 55 | 18.4 M | $379 M |
| 2020 Q3 | 54 | 16.3 M | $429 M |